Studiesin children with JIA found that ADAs to golimumab did not appear to have impacton clinical responses.39,57 Brunner et al. 39 reported that none of the eight JIA patients found with high ADA titres>1:1000, experienced flares. Here, ADA is linked to juvenile idiopathic arthritis.